Femlyv FDA Approval History
FDA Approved: Yes (First approved July 22, 2024)
Brand name: Femlyv
Generic name: ethinyl estradiol and norethindrone acetate
Dosage form: Orally Disintegrating Tablets
Company: Millicent Puerto Rico LLC
Treatment for: Birth Control
Femlyv (ethinyl estradiol and norethindrone acetate) is an orally disintegrating tablet formulation of an approved estrogen and progestin combination indicated for use by females of reproductive potential to prevent pregnancy.
Development timeline for Femlyv
| Date | Article |
|---|---|
| Jul 23, 2024 | Approval FDA Approves Femlyv (norethindrone acetate and ethinyl estradiol) Orally Disintegrating Birth Control Pill |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
